Keywords: sanofi, initiates, ph, ii, trial, melanoma, vacc

Sanofi initiates Ph II trial of melanoma vacc

Article | 29 September 2008

Print This

Sanofi Pasteur, the vaccines division of French drug major Sanofi-Aventis, is sponsoring a Phase II study exploring a multi-pronged treatment ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in